
Commentary: targeting myelodysplastic syndromes.
Publication
, Journal Article
de Castro, CM
Published in: Leuk Res
August 2002
Duke Scholars
Published In
Leuk Res
DOI
ISSN
0145-2126
Publication Date
August 2002
Volume
26
Issue
8
Start / End Page
703
Location
England
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Myelodysplastic Syndromes
- Immunology
- Humans
- Drug Design
- Cytokines
- Antineoplastic Agents
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
de Castro, C. M. (2002). Commentary: targeting myelodysplastic syndromes. Leuk Res, 26(8), 703. https://doi.org/10.1016/s0145-2126(02)00024-3
Castro, Carlos M. de. “Commentary: targeting myelodysplastic syndromes.” Leuk Res 26, no. 8 (August 2002): 703. https://doi.org/10.1016/s0145-2126(02)00024-3.
de Castro CM. Commentary: targeting myelodysplastic syndromes. Leuk Res. 2002 Aug;26(8):703.
de Castro, Carlos M. “Commentary: targeting myelodysplastic syndromes.” Leuk Res, vol. 26, no. 8, Aug. 2002, p. 703. Pubmed, doi:10.1016/s0145-2126(02)00024-3.
de Castro CM. Commentary: targeting myelodysplastic syndromes. Leuk Res. 2002 Aug;26(8):703.

Published In
Leuk Res
DOI
ISSN
0145-2126
Publication Date
August 2002
Volume
26
Issue
8
Start / End Page
703
Location
England
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Myelodysplastic Syndromes
- Immunology
- Humans
- Drug Design
- Cytokines
- Antineoplastic Agents
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences